Group One Trading’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-216,700
Closed -$1.06M 5438
2016
Q4
$1.06M Buy
216,700
+210,100
+3,183% +$1.08M 0.01% 1282
2016
Q3
$33K Sell
6,600
-2,700
-29% -$13.8K ﹤0.01% 3576
2016
Q2
$47K Sell
9,300
-57,900
-86% -$312K ﹤0.01% 3346
2016
Q1
$384K Sell
67,200
-70,100
-51% -$490K 0.01% 1869
2015
Q4
$1.43M Buy
137,300
+96,100
+233% +$1.3M 0.02% 1076
2015
Q3
$761K Sell
41,200
-172,000
-81% -$3.32M 0.01% 1454
2015
Q2
$4.15M Buy
213,200
+97,000
+83% +$1.72M 0.06% 395
2015
Q1
$2.04M Buy
116,200
+26,600
+30% +$447K 0.03% 625
2014
Q4
$1.43M Sell
89,600
-41,600
-32% -$557K 0.02% 837
2014
Q3
$1.65M Buy
131,200
+29,100
+29% +$415K 0.03% 802
2014
Q2
$1.59M Sell
102,100
-50,000
-33% -$735K 0.02% 836
2014
Q1
$2M Buy
152,100
+27,400
+22% +$429K 0.03% 622
2013
Q4
$2M Buy
124,700
+50,600
+68% +$806K 0.03% 655
2013
Q3
$1.23M Buy
74,100
+34,300
+86% +$507K 0.02% 863
2013
Q2
$401K Buy
+39,800
New +$418K 0.01% 1530

Other funds holding OSIR

Group One Trading's OSIR Position: Q4 2018 in Review

Group One Trading sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2018, closing a stake of 66 shares — an estimated $1K sold.

Group One Trading first reported a position in OSIR in Q2 2013 and held it in 16 quarters. The position peaked at $1.35M in Q3 2014. 46 funds tracked by Wall St. Rank hold OSIR as of Q4 2018.

  • Group One Trading reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Group One Trading sold 66 Osiris Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $1K.
  • Group One Trading first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • Group One Trading's Osiris Therapeutics, Inc. Common Stock position peaked at $1.35M in Q3 2014.
  • 46 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.